Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEMATIS phase 2 study of RO5186582 in adolescents and adults with Down syndrome
2013-001263-23Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Down syndrome comparing RO5186582 with Placebo (2 arms). Primary endpoint: Cognition assessed by RBANS sub-tests. Started Dec 2013; status: completed.
02
Drugs
basmisanil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on 2013-001263-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001263-23.